Antiviral Textile Performance Testing
topic
Antiviral testing deposits defined titres of influenza H1N1, SARS-CoV-2 surrogate phages, or bacteriophage MS2 onto treated fabric specimens, incubates for defined contact times, then quantifies surviving viral titre by plaque assay or RT-PCR, calculating log reduction relative to untreated control specimens at equivalent contact times.
Role
Validates virucidal claims for copper-treated, photocatalytic, and biopolymer-coated textiles used in healthcare masks, surface wipes, and high-touch fabric applications where virus inactivation on textile surfaces reduces cross-contamination risk in clinical and public health settings.